Institute of Inflammation and Ageing World leading discovery and translational science in inflammation and ageing
News Latest research finds hypertension drug could be repurposed to delay ageing Latest research has found that rilmenidine, a drug used to treat hypertension, can be used to slow ageing and extend lifespan.
News Inflammation and Ageing Research Fellow receives £1.2M Competitive MRC Career Development Fellowship
News Latest study uncovers findings of periodontal therapy in reducing rheumatoid arthritis disease activity
15 October 2020 University receives two awards to mark gender equality The College of Medical and Dental Sciences has achieved the Athena SWAN Silver award from the Athena SWAN Foundation, recognising the College's commitment to gender equality.
07 October 2020 Vitamin D deficiency increased risk of COVID in healthcare workers, new UK study shows Research finds healthcare workers who self-isolated after developing COVID-19 symptoms were more likely to have a vitamin D deficiency, with workers from Black, Asian or ethnic minority backgrounds particularly affected.
21 September 2020 How lupus patients would like to be treated: study identifies physician behaviours that help build trust and medical security Lupus patients – and those with related systemic autoimmune diseases – often experience persisting medical insecurity and negative healthcare-behaviours.
11 August 2020 Coronavirus-related children's diseases linked to blood cell changes A disease occurring in children and linked to COVID-19 has significant changes in white blood cells.
28 July 2020 Researchers discover chemical messenger that instructs tissue cells to become aggressive A University of Birmingham team have established that a chemical messenger released by blood vessels instructs tissue cells to become aggressive and destroy joints, a classic symptom of rheumatoid arthritis.
14 July 2020 UK children's intensive care units come together to offer first nationwide insight into new condition in children thought to be related to COVID-19 A UK study into critically ill children admitted to paediatric intensive care units with symptoms of a rare, new inflammatory syndrome, has offered the first nationwide insights into the true extent of the condition.